+61 (0) 419 185 491
+61 (0) 411 816 444
PO Box 636 Bondi Junction
NSW 1355
Australia
admin@lara.org.au
The LAM Australasia Research Alliance (LARA) is dedicated to improving the health prospects of women with LAM in Australia, New Zealand and throughout the region. A disease that affects only women, LAM is rare and often devastating.
ALL DONATIONS TO LARA ARE FULLY TAX DEDUCTIBLE
Your contribution to LARA will go 100% to funding vital medical research to find a cure for LAM.
You can donate to the LAM Australasia Research Alliance by sending us a cheque, using our PayPal facility, or by making a deposit directly to our ANZ Bank account: 012 055 4926 67193.
Please advise us of your donation by sending an email to admin@lara.org.au with your name, address and email address. We will respond with our thanks and a fully tax deductible receipt.
Major Donors
Macquarie Group Foundation
Roth Charitable Foundation
Mr Robert Gavshon
Hollick Wines
Acknowledgements
LARA thanks the professionals who work pro bono for this not-for-profit organisation. We highly recommend the services of:
Ben Higham, Webhead
Karen Riethmuller, KGR Design
Peter Hersh, Loggica Pty Ltd
Peter Kelso
|
Malaghan Scientific Research
|
Malaghan Scientific ResearchIn November 2009 researchers at the Malaghan Institute for Medical Research in Wellington New Zealand embarked on a one year pilot program studying LAM cells.This research initiative by the Malaghan Institute's Cancer Cell and Molecular Biology Group is supported by The New Zealand LAM Trust and the LAM Australasia Research Alliance (LARA). The project is investigating the cancer-like properties of LAM cells - specifically, whether LAM cells can grow in culture under conditions that support the growth of self-renewing cancer cells. The big question is whether LAM cells grown in these conditions express self renewal genes typical of cancer stem cells. The pilot study is the initial stage of a proposed three year study to be undertaken by Prof Mike Berridge and his team at the Institute in collaboration with Dr Lyn Moir working under the direction of Prof Judith Black AO in the Department of Pharmacology at the University of Sydney. The larger study will explore the feasibility of treating LAM by using the immunological therapies currently being developed for treating cancer.The Australian and New Zealand LAM organisations are funding this project with contributions from large and small donors, with some of the money raised coming from events organised by women with LAM themselves. LARA and the NZ LAM Trust wish to thank all their supporters for making this crucial research possible. We wish the research team success in the first year of this exciting program. ![]() |